Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

Special Report

NeurologyLive Peer Exchange

Medcast

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Articles

A recent matched cohort analysis revealed that patients with CIDP treated with immunoglobulin had lower rates of assistive device deterioration and opioid use compared with those untreated.

Real-World Study Highlights Reduced Disability Progression of CIDP With Immunoglobulin Therapy

Matched analysis from the IGOS dataset showed ANX005-treated patients had greater improvements in GBS disability scores over time compared with those receiving IVIg or plasma exchange.

ANX005 Outperforms IVIg and Plasma Exchange in Improving Guillain-Barré Syndrome Outcomes

Videos

The neurologist at the Hospital de la Santa Creu, in Barcelona, Spain, outlined the goals and significance of the VITALIZE and MOBILIZE phase 3 trials evaluating riliprubart in standard-of-care and treatment-refractory CIDP populations. [WATCH TIME: 3 minutes]

Outlining Phase 3 VITALIZE and MOBILIZE Trials of Riliprubart in CIDP: Luis Querol, MD, PhD

AHN's neuro-oncology program aims to revolutionize brain and spine tumor care with innovative therapies, personalized treatment plans, and advanced research initiatives.

Rewiring Brain and Spine Tumor Care: AHN’s Coordinated, Personalized Approach   

, has been with the team since September 2022. Follow her on Twitter 

The assistant professor of neurology at Robert Wood Johnson Medical School discussed the mission of RCASIA, highlights from its annual retreat, and key takeaways from AAN 2025.

NeuroVoices: Brad Kamitaki, MD, on Aiming to Improve Dementia Care in Asian and Pacific American Communities

The executive vice president of research at the National MS Society talked about the significance of the Dystel Prize, honoring researchers in MS whose scientific work has led to meaningful diagnostic or therapeutic advancements. [WATCH TIME: 2 minutes]

Recognizing Scientific Excellence and Impact in Multiple Sclerosis Research: Bruce Bebo, PhD

The research portfolio director at the Muscular Dystrophy Association discussed the evolving ALS therapeutic landscape, highlighting advances in genetic and RNA-based interventions. [WATCH TIME: 6 minutes]

Advancing ALS Through Gene Therapies, Early Intervention, and Multidisciplinary Care: Brian Lin, PhD

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

PNS 2025

AAN 2025

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

News Network

 video series brings together expert clinicians and patients with neurologic diseases and disorders to discuss the landscapes of care, management, and treatment from both perspectives.

1rem

CURE Connections®

In an upcoming Cure Connections program entitled “Barriers to Addressing Sleep Health in Clinical Practice” Dr Paul Doghramji will talk to a patient with insomnia and discuss challenges patients and physicians face when talking about sleep issues and in adequately treating insomnia.

Barriers to Addressing Sleep Health in Clinical Practice

In this program,we will discuss the management of multiple sclerosis (MS) from physician and patient perspectives. In particular, we will discuss a patient’s diagnosis journey, the importance of comprehensive care, and resources for the MS community.

The Patient Journey in the Management of Multiple Sclerosis

Joseph E. Sullivan, MD; Kelly Knupp, MD; Mary Anne Meskis; and Tracy Dixon-Salazar, PhD, share insight on the patient and provider journey of LGS and Dravet syndrome, from diagnosis through treatment.

Dravet Syndrome and Lennox-Gastaut Syndrome: Perspectives from the Patient Journey

Crystal Proud, MD, and Craig Zaidman, MD, discuss the importance of SMA screening, diagnosis of SMA in children and adolescents through telehealth, and demonstrate the process of a real telehealth appointment with patients.

The Identification and Evaluation of Suspected Spinal Muscular Atrophy (SMA) in Children and Adolescents During a Telehealth Appointment

Recommendations for identifying neuromyelitis optica spectrum disorders in the community and using immunosuppressive therapy to help prevent acute attacks.

Managing Neuromyelitis Optica Spectrum Disorders (NMOSD)

A panel including an expert neurologist give their perspectives on overall management of progressive multiple sclerosis and the impact of COVID-19.

Strategies for Managing Progressive Multiple Sclerosis During COVID-19

The NeurologyLive Cure Connections series, “Evaluation of Spinal Muscular Atrophy in the Era of Telehealth,” put on in partnership with Cure SMA, features Diana Castro, MD, and Garey H. Noritz, MD, who offer tips and demonstrations for screening and diagnosing SMA via telehealth. Additionally, resources provided by Cure SMA are outlined for families and clinicians who suspect SMA or have a patient diagnosed with SMA.

Cure SMA:  Evaluation of SMA in the Era of Telehealth

Patient and clinician insight regarding the challenges associated with migraine and best approaches to preventing and managing attacks with lifestyle intervention and newer therapies. 

The Migraine Patient Journey: Episodic Migraine and CGRP Inhibitors

A diverse panel including an expert neurologist, psychologist, patient, and care partner give their perspectives on various facets of multiple sclerosis.

The Multiple Sclerosis Patient Journey

Spinal Muscular Atrophy (SMA): Physician and Patient Management